Summary
The proposed research is directly relevant to public health as it focuses on understanding the mechanisms that underlie autoimmunity in type 1 diabetes, multiple sclerosis and rheumatoid arthritis. Furthermore, it will provide insight into the patient response to therapy targeting the interleukin-6 receptor.